“SMRT-GPS2 corepressor pathway dysregulation coincides with obesity-linked adipocyte inflammation” Amine Toubal,1,2,3,4 Karine Clément,1,2,3,4 Rongrong Fan,5 Patricia Ancel,1,2,3,4, Veronique Pelloux,1,2,3,4 Christine Rouault,1,2,3,4 Nicolas Veyrie,1,2,3,4, Agnes Hartemann,1,4,6 Eckardt Treuter,5 and Nicolas Venteclef1,2,3,4 1 Institute of Cardiometabolism and Nutrition, Paris, France. 2 Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Heart and Metabolism Division, Paris, France. 3 Unité Inserm 872, Team 7 Nutriomique, Paris, France. 4 Université Pierre et Marie Curie-Paris 6, Cordeliers Research Center, Paris, France. 5 Karolinska Institutet, Center for Biosciences, Department of Biosciences and Nutrition, Huddinge, Sweden. 6 Assistance-Publique-Hôpitaux de Paris, Pitié-Salpêtrière, Hospital, Endocrinology, Nutrition and Diabetes Department, Paris, France. The Journal of Clinical Investigation, janvier 2013, volume 123, n°1 http://dx.doi.org/10.1172/JCI64052 (accessible après la levée de l’embargo)